Clinical care guideline: Chronic suicidality

Persistent, long-term suicidal ideation or recurrent self-injurious behavior presents a distinct clinical challenge compared to acute suicidal crisis. Often associated with complex trauma, personality disorders, or treatment-resistant mood conditions, managing chronic suicidality requires balancing ongoing risk management with skill acquisition for clients. Unlike acute suicide episodes that escalate quickly and playout in a short time-scale, chronic suicide risk tends to be more stable over time - for weeks, months, or even years. Frequent hospital admissions for baseline suicidal ideation can cause inadvertent harm, making consistent, structured outpatient care the preferred setting for effective treatment.

This care guideline offers a brief summary of the evidence-based, best practices for the effective treatment of adults experiencing chronic suicidality.

Diagnostic considerations for chronic suicidality in adults

Chronic suicidality involves persistent thoughts of suicide or recurrent suicidal behavior that endure over months or years, often serving as a habitual coping mechanism for severe, persistent emotional distress. 

Core clinical features:

  • Duration and habituation: Ideation is passive or active, recurring continuously or semi-continuously rather than during isolated episodic crises.
  • Acute vs. chronic distinction: Chronic suicidality represents a patient's baseline state of distress, whereas acute suicidality involves a sudden spike in intent, plan, or driving urgency.
  • Associated conditions: Commonly observed in borderline personality disorder (BPD), complex PTSD (C-PTSD), or persistent depressive disorder. 
  • Underlying drivers: Often fueled by feeling like a burden, a continual sense of not belonging, low ability to tolerate distress/discomfort, and difficulty with emotional regulation.

Symptom screening and monitoring

Using Measurement-Informed Care tools in cases of chronic suicidality provides an objective baseline, allowing clinicians to distinguish routine fluctuations from acute escalation, including:

  • Establish and track the client's baseline severity of ideation over time.
  • Identify subtle shifts from passive baseline ideation to active intent or plan.
  • Document ongoing medical necessity and therapeutic progress.
  • Evaluate the efficacy of distress tolerance and emotion regulation interventions.

The Columbia-Suicide Severity Rating Scale (C-SSRS) is a brief, validated tool used to assess the presence, frequency, and severity of suicidal ideation and behavior. Routine use of this measure is foundational to providing effective care for individuals who experience chronic suicidality, as it supports establishing an accurate baseline versus acute spikes. This measure can be useful in identification of treatment plan goals based on symptom severity, and can guide effective clinical interventions. 

The PHQ-9 measure can capture key information about depressive symptom severity, and includes a question regarding thoughts about being better off dead or wanting to hurt yourself (question 9).  Visit the Therapist Help Center to learn more about incorporating Measurement-Informed Care in sessions. 

In addition to the C-SSRS, consider using the SAFE-T protocol or utilizing additional probing questions to make your assessment more comprehensive:

  • How many days per week do you think about suicide?
  • How long do you typically think about suicide? (hours vs. fleeting)
  • What specific thoughts do you experience? (quotes)
  • Do you notice a common theme for when these thoughts arise? (time of day, triggered by conflict, triggered by loneliness, etc.)
  • When do you first remember thinking about suicide?
  • When have your thoughts become more intense (frequency, duration, intensity of thoughts)
  • When have these thoughts been the least severe? (frequency, duration, intensity)
  • When these thoughts arise, what emotions tend to come with these thoughts? (anxiety, fear, relief, etc.)

Ultimately, the goal is to measure symptoms in a way that best identifies when a spike in suicidality occurs beyond the client’s baseline fluctuations. This includes monitoring for when suicidal ideation moves away from something the client uses as a habitual coping strategy (i.e. using the thought as comfort of an escape, without intention to act), and catching when it escalates to an imminent risk to safety. 

Evidence-based approaches to treatment

Psychotherapy

Structured psychotherapy focusing on skill acquisition, emotion regulation, and collaborative risk management is the primary treatment for chronic suicidality:

  • Dialectical Behavior Therapy (DBT): Gold-standard intervention for chronic suicidality and self-harm. Focuses on four core skill modules: mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness.
  • Collaborative Assessment and Management of Suicidality (CAMS): A clinician-patient framework that directly targets patient-defined suicidal drivers, emphasizing co-authoring treatment plans.
  • Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP): Focuses on cognitive restructuring of suicidal beliefs, developing adaptive problem-solving skills, and constructing a physical or digital coping kit.
  • Safety Planning Intervention (SPI): A dynamic, continuously updated plan prioritizing internal coping strategies, social distractions, and environmental safety. Visit the Rula Help Center article, How to Collaborative Create a Safety Plan with Clients for more information. 

Medication

While there are no medications specifically indicated by the U.S. Food and Drug Administration (FDA) to eliminate suicidal ideation alone, certain psychiatric medications have demonstrated efficacy in reducing suicidal behavior and treating underlying co-occurring conditions. Examples with strong clinical evidence include:

  • lithium (Lithobid) – shown to significantly reduce the risk of suicide in individuals with bipolar disorder and major depressive disorder
  • clozapine (Clozaril) – FDA-approved specifically for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder
  • Selective serotonin reuptake inhibitors (SSRIs) – commonly used to treat underlying mood and anxiety disorders that contribute to chronic suicidal distress

Medications with high toxicity in overdose (such as tricyclic antidepressants) or those that can increase disinhibition (such as benzodiazepines) require careful evaluation and are generally used with caution in individuals experiencing chronic suicidality.

When should I refer my client for psychiatric medication management?

Medication can be useful in treating chronic psychiatric conditions that may be contributing to suicide risk. Clients with moderate to severe chronic suicidal ideation or co-occurring mood instability may benefit from discussing the use of medication (in conjunction with continued therapy) with a prescribing clinician to maximize treatment response, support mood stabilization, and reduce overall symptom distress.

noun-lightbulb-1262995.png As a reminder, it is beyond the scope of a psychotherapist to suggest specific medications, groups of medications, specific supplements, or advise on the frequency of taking or stopping medications. These discussions must only be carried out by a prescribing medical provider.

Clinical resources to support treatment

To support your work with clients experiencing chronic suicidality, consider utilizing structured tools designed to increase distress tolerance and streamline risk management:

Assessing risk and higher level of care needs

Managing chronic suicidality requires careful calibration to avoid unnecessary over-hospitalization while maintaining safety.

  • Differentiating baseline from acute escalation: Avoid automatic emergency room referrals for routine, baseline ideation without intent or plan. Unnecessary admissions can disrupt outpatient skill building and reinforce avoidance mechanisms. It is important to assess this at each session.
  • Lethal means restriction: Continuously assess and evaluate access to lethal means (e.g., securing firearms, locking up medications, safe storage of sharp objects). This remains the single most effective environmental safety intervention.
  • When to elevate care: Step up to Partial Hospitalization Programs (PHP), Intensive Outpatient Programs (IOP), or crisis stabilization when there is a sudden, clear surge in active intent, explicit planning, loss of impulse control, or breakdown of the collaborative safety agreement.
  • Documentation & reassessment: Document the client's historical baseline versus their presentation today, steps taken to restrict lethal means, safety plan reviews, and the clinical rationale for maintaining care in the least restrictive setting.

Cultural considerations

Suicidal ideation, risk factors, and safety planning are deeply influenced by cultural context, identity, systemic equities, and historical experiences with healthcare systems:

  • BIPOC populations: Systemic racism, discrimination, microaggressions, and racial trauma significantly contribute to chronic psychological distress in Black, Indigenous, and People of Color (BIPOC) populations. Clinicians should recognize that distress may present through somatic complaints, emotional withdrawal, or cultural idioms of distress rather than explicit verbalizations of suicidal intent.
  • LGBTQI+ populations and affirming care: Elevated rates of chronic suicidality in LGBTQI+ individuals are driven by chronic minority stress rather than identity itself (ex. social stigma, identity invalidation, housing or employment discrimination, and family rejection). Establishing an identity-affirming environment by using correct names/pronouns, validating lived experiences, and identifying chosen family networks acts as a vital clinical buffer.
  • Stigma and disclosure: Cultural, religious, or community-based stigma around mental illness and suicide can create fear of shaming one's family or community. This often delays help-seeking behavior and leads to underreporting during standard screenings. Clinicians should foster a non-judgmental space that normalizes conversations around distress and suicide.
  • Community and protective factors: Identify and integrate culturally specific protective factors into safety planning. This may include spiritual practices, multi-generational family support, chosen families, or tribal/community ties, while remaining sensitive to potential fears of relational rupture or identity rejection.
  • Historical and systemic trauma: Deep-seated mistrust of healthcare and law enforcement institutions rooted in historical abuses, systemic racism, and coercive or non-affirming emergency interventions, can make clients hesitant to seek traditional crisis services. Safety planning should prioritize community-based, non-coercive, and culturally safe crisis resources whenever possible.

Disclaimer: Chronic suicidality in children and adolescents

While chronic suicidality is frequently evaluated in adults, persistent ideation and non-suicidal self-injury (NSSI) are increasingly observed in pediatric and adolescent populations.

Common pediatric presentation / early signs:

  • High frequency of self-injurious behavior (e.g., cutting, burning) without explicit intent to die, requiring clinical clarification from true suicidal intent.
  • Mandatory inclusion of parents/caregivers in safety planning, lethal means restriction, and emotional validation.
  • School integration and coordinating with school counselors to ensure daily safety accommodations without alienating or stigmatizing the student.

Explore these pediatric resources: 

Always be sure to involve a minor’s trusted caregiver in cases when the child endorses suicidality. 

References

American Psychiatric Association. (2023). The American Psychiatric Association practice guideline for the assessment and treatment of patients with suicidal behaviors. APA Publishing.

Jobes, D. A. (2016). Managing suicidal risk: A collaborative approach (2nd ed.). The Guilford Press.

Joiner, T. (2005). Why people die by suicide. Harvard University Press.

Linehan, M. M. (2015). DBT skills training manual (2nd ed.). The Guilford Press.

Stanley, B., & Brown, G. K. (2012). Safety planning intervention: A brief intervention to mitigate suicide risk. Cognitive and Behavioral Practice, 19(2), 256–264. https://doi.org/10.1016/j.cbpra.2011.01.001

Updated

Was this article helpful?

0 out of 0 found this helpful